Acta Cirúrgica Brasileira (May 2018)

Capsiate treatment in liver surgeries may compromise its recovery

  • Pedro Paulo Barros,
  • Gisele Mara Silva Gonçalves,
  • Gustavo Henrique da Silva,
  • Maria Clara Villaça Dias Bastos,
  • Loren Nogaroto Ramos,
  • Marilia Marinello Fernandes

DOI
https://doi.org/10.1590/s0102-865020180050000006
Journal volume & issue
Vol. 33, no. 5
pp. 439 – 445

Abstract

Read online Read online

Abstract Purpose: To investigate the effects of capsiate treatment on hepatic hyperplasia in partially hepatectomized rats. Methods: The animals were divided into a Capsiate group (CPH), a Capsiate Post-Partial Hepatectomy group (CPPH) and a Partial Hepatectomy Control group (PH). CPH and CPPH animals received 60 mg/kg/day Capsiate for 30 days. Next, the rats underwent partial hepatectomy. CPPH animals continued to receive treatment for 48 h after partial hepatectomy. Liver tissue and intracardiac blood samples were obtained 24 or 48 h after PH. Results: Capsiate treatment interfered with hepatic parameters, reducing the number of mitoses and apoptosis and increasing blood ALT and alkaline phosphatase concentrations. Conclusion: Capsiate treatment preceding hepatic surgery may compromise the initial period of postoperative recovery.

Keywords